Global University Venturing

Forge is working on a gene therapy treatment invented at UPMC but has covered its bases by targeting viral vector production for third-party clients.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Frontier IP attracted $2.9m in a placement that will support its portfolio in responding to coronavirus-related challenges or opportunities.

Jackson State University will helm the Enrich initiative to engage health innovators from 25 historically-black US colleges and universities.

Tübingen's messenger RNA vaccine and drug developer's latest round includes a $171m investment by strategic partner GlaxoSmithKline.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Scalable Capital is valued in excess of $460m following a round that lifted the digital wealth manager's total funding to about $130m.

UC Berkeley's genetic drug developer 4DMT has pulled away from a proposed $100m offering after closing series C funding last month.

Mingdu Intelligent, backed by three Chinese academic institutions, has increased its funding haul to at least $26m.

Vesigen has attracted Leaps by Bayer to commercialise drug delivery technology invented by Quan Lu at Harvard School of Public Health.

Dexterity, a logistics robot spinout of Stanford, has emerged from stealth with series A funding and debt financing from Stanford-StartX Fund.